Daily Stock List
International Isotopes, Inc. (INIS)
SmallCapVoice reported earlier on International Isotopes, Inc. (INIS), and we report on the Company today, here at the QualityStocks Daily Newsletter.
International Isotopes, Inc. manufactures a complete collection of nuclear medicine calibration and reference standards, and an assortment of cobalt-60 products, including teletherapy sources. Additionally, the Company provides a broad array of radiological field services on a contract basis to clients. It also provides a wide-ranging selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications. International Isotopes is headquartered in Idaho Falls, Idaho. The Company lists on the OTC Bulletin Board.
International Isotopes business segments include the Depleted Uranium De-Conversion and Fluorine Extraction Process (FEP) Project; Radiochemicals for Cancer Treatment; Nuclear Medicine Reference and Calibration Standards; Medical Teletherapy Products, AOS Series Type B (U) Transportation Containers, and Transportation Services. The Company has developed a unique process to convert depleted uranium tails (the by-product generated from the enrichment of uranium) to ultra-high purity, high value industrial fluoride products.
International Isotopes is working to advance its planned environmentally friendly, green technology, uranium de-conversion and fluorine extraction processing facility in Lea County, approximately 15 miles west of Hobbs, New Mexico. The new facility will be on a 640-acre site.
International Isotopes’ belief is that this new commercial facility will provide a first-rate commercial opportunity. The Company holds patents that give it exclusive rights for the Fluorine Extraction Process (FEP). This process produces high value, high purity fluoride gasses in union with uranium de-conversion. International Isotopes exclusively owns the patents for the fluorine extraction process.
International Isotopes’ de-conversion process will convert the DUF6 by-product (or tails) from uranium enrichment operations into depleted uranium tetrafluoride (DUF4). The Company will then employ its patented FEP technology to extract fluorine from the DUF4 for use in the manufacture of specialty, high-value fluoride gases.
This past November, International Isotopes announced financial results for Q3 and nine months ended September 30, 2016. Revenue for the three months ended September 30, 2016 was $1,411,263 versus $1,609,061 for the same period in 2015. This represents an overall decrease of roughly 12 percent.
Revenue for the nine-month period ended September 30, 2016 was $4,801,672, versus $5,125,918 for the same period in 2015. This represents a decrease of roughly 6 percent. The Company said that the drop in revenue for both periods was mainly because of the decrease in revenue in the radiological services and cobalt products segments.
International Isotopes’ net loss for the three months ended September 30, 2016 was $539,357, versus $644,488 for the same period the year prior. This represents a decrease in loss of about 16 percent. The Company’s net loss for the nine-month period ended September 30, 2016 was $1,359,302 versus $1,263,528 for the same period the year prior, an increase of around 8 percent.
International Isotopes, Inc. (INIS), closed Friday's trading session at $0.08, up 14.12%, on 685,325 volume with 37 trades. The average volume for the last 60 days is 109,650 and the stock's 52-week low/high is $0.0502/$0.139.
ULURU, Inc. (ULUR)
Marketbeat, Innovative Marketing, Zacks, TopPennyStockMovers, BabyBulls, and SmallCapVoice reported on ULURU, Inc. (ULUR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
ULURU, Inc. is a specialty pharmaceutical company centering on the development of a portfolio of wound management and oral care products. This is to provide patients and consumers improved clinical outcomes by way of controlled delivery using the Company’s inventive Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system. ULURU has its corporate headquarters in Addison, Texas.
The Company’s strategy is to develop and commercialize a customer-focused portfolio of innovative wound care products to treat the different phases of wound healing. In addition, ULURU’s strategy involves developing the oral-transmucosal technology and producing revenues via numerous licensing agreements.
ULURU’s products include Altrazeal®. It developed and commercializes Altrazeal® - a transforming powder dressing with proprietary Nanoflex® technology, for the management of exuding wounds. Altrazeal® is a scientifically engineered advanced wound dressing designed to incorporate the desired features and benefits of the ideal wound dressing.
Altrazeal® has demonstrated potential clinical and economic advantages in numerous chronic and acute wounds. These include diabetic foot ulcers, venous leg ulcers, as well as geriatric wounds.
ULURU also has its patented delivery strip for whitening teeth, which completely erodes (OraDisc™ W- Erodible Whitening Strip for Teeth). This proprietary tooth whitening product consists of a laminated bilayer strip that utilizes the OraDisc™ technology.
The Company additionally has its OraDisc™A. It developed OraDisc™ A, a novel mucoadhesive, water-erodible disc incorporating 2mg of amlexanox, for the treatment and prevention of aphthous ulcers. OraDisc™ B is a mucoadhesive erodible disc containing 15 mg of benzocaine, developed for the treatment of oral pain.
ULURU entered into a cooperation agreement with Saraya Co. Ltd. for the registration of Altrazeal® and further cooperation in Japan. Saraya engages in the development, manufacture, distribution, and sales of an array of human health, sanitation, hygiene products, and related equipment in Japan and globally. ULURU also entered into a licensing and distribution agreement with Juthis Corp. of South Korea. This is for the marketing, sale and distribution of Altrazeal® in Malaysia and South Korea.
This past November, ULURU announced its financial results for Q3 ended September 30, 2016. The Company reported a net loss of roughly $686,000, or $0.01 per share, versus a net loss of roughly $866,000, or $0.03 per share, for the same period in 2015. For the nine months ended September 30, 2016, ULURU reported a net loss of roughly $1,869,000, or $0.03 per share, versus a net loss of roughly $2,334,000, or $0.09 per share, for the same period in 2015.
ULURU, Inc. (ULUR), closed Friday's trading session at $0.099, up 23.75%, on 39,498 volume with 6 trades. The average volume for the last 60 days is 47,761 and the stock's 52-week low/high is $0.0301/$0.30.
biOasis Technologies, Inc. (BIOAF)
OTC Markets Group, SmallCapFinancialWire, and PennyStocks24 reported on biOasis Technologies, Inc. (BIOAF), and we also report on the Company, here at the QualityStocks Daily Newsletter.
biOasis Technologies, Inc. is a biopharmaceutical company focusing on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB). The Company is developing and commercializing a proprietary brain delivery technology to address unmet medical needs in the treatment of Central Nervous System (CNS) disorders. biOasis has its Transcend Platform, currently being licensed to biotechnology and pharmaceutical companies for the advancement of their neurotherapeutic programs. biOasis Technologies has its headquarters in Richmond, British Columbia.
The founding scientist at biOasis Technologies is Dr. Wilfred Jefferies, Professor in the Michael Smith Laboratories at The University of British Columbia. Transcend was discovered in the 1990’s in Dr. Jefferies’ laboratory at the Michael Smith Laboratories at The University of British Columbia.
The Transcend Platform consists of a varied set of peptide carriers and linkers. These together provide transport solutions for a variety of CNS therapeutics. These include monoclonal antibodies, enzymes, small molecules, and assorted types of gene therapies. The basis of the Transcend Platform is on Receptor Mediated Transcytosis. This is nature’s own way of carrying compounds into the brain.
The design of the Transcend Platform is to deliver high concentrations of therapeutics into the CNS with minimal dosing requirements and with no disruption of the blood-brain barrier. The Transcend platform has been shown to effectively transport antibodies, biological agents, enzymes, and small molecules drugs across the blood brain barrier, enter into specific brain cells, and localize in the proper intracellular compartments.
In September 2016, biOasis Technologies announced that it entered into a License Agreement with Vaccinex, Inc. With this Agreement, Vaccinex will have the right to commercialize its anti-semaphorin 4D (anti-SEMA4D) antibody technology in combination with the biOasis Transcend technology. The Vaccinex anti-SEMA4D technology targets neurodegenerative diseases including Huntington's disease and multiple sclerosis, the two initial neurology disease indications undergoing investigation by Vaccinex.
Recently, biOasis Technologies announced that Dr. Paul Lockman's earlier published paper on biOasis' Transcend technology linked to Trastuzumab was honored by being featured on the cover of the December issue of Pharmaceutical Research, Volume 33, Issue 12. The Lockman paper, entitled, "Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: An In-Vivo Study
," was published in Pharmaceutical Research, an official Journal of the American Association of Pharmaceutical Scientists.
biOasis Technologies, Inc. (BIOAF), closed Friday's trading session at $0.82, down 1.55%, on 1,700 volume with 4 trades. The average volume for the last 60 days is 11,610 and the stock's 52-week low/high is $0.7157/$1.55.
AngioSoma, Inc. (SOAN)
Greenbackers, NanoCap Gems, and Market Pulse reported on AngioSoma, Inc. (SOAN), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
OTCQB-listed, AngioSoma, Inc. is a clinic stage biotechnology company based in Montgomery, Texas. The Company provides advanced drug delivery systems. AngioSoma is focused on improving the effectiveness of current standard-of-care treatments related to endovascular interventions for peripheral artery disease (PAD). Liprostin™ is the Company’s lead PAD treatment product candidate.
The Company’s subsidiaries are AngioSoma Research, Inc. (Texas), and First Titan Energy LLC (Nevada). First Titan Energy has oil & gas assets and it will be spun off to shareholders to permit AngioSoma to concentrate on biotechnology. First Titan Energy contains all the AngioSoma oil & gas assets.
AngioSoma Research was the subsidiary with all the intellectual property (IP), which was purchased in June of 2016 that was a precursor to First Titan renaming itself to AngioSoma, Inc.
Regarding the above-mentioned Liprostin™, it successfully completed U.S. Food and Drug Administration (FDA) required Phase I and II clinical trials. Furthermore, Liprostin™ is entering the final phase before approval, Phase III trials.
Liprostin™ is an FDA-approved product in a new controlled delivery system, a sterically stable liposome that has made AngioSoma’s product, the familiar generic ProstaglandinE1 (PGE1), a brand new drug with a brand new controlled delivery.
AngioSoma also has a strong product pipeline with existing and provisional patents, formulations, and trademarks targeted at improving the standard-of-care in treating PAD with stents, reabsorb-able stents, atherectomy catheters, and tunneling catheters.
In September 2016, AngioSoma announced the formation of the Soma Nutraceuticals, Inc. subsidiary. This is for the acquisition and marketing of proven nutraceutical products, and acquisition discussions with many proven nutraceutical intellectual properties. Soma Nutraceuticals is the recipient of IP conveyed by its Chairman Emeritus Dr. David Summers. This includes a nutraceutical product using either natural or synthetic nicotine in a patented method for substantially accelerating the development of muscle mass and strength (U.S. Patent 7,074,812, “Development of Muscle Mass in a Mammal”).
AngioSoma announced in October 2016 a joint venture (JV) with La Jolla Capital Partners LLC, focused on the funding and management of FDA Liprostin™ Phase III trials, and the licensing of Liprostin™ internationally, afterward. The Company also announced in October that it filed three new patent applications associated with Liprostin™. The new patents include transdermal skin patches and other methods of treating atherosclerosis, usually called Peripheral Artery Disease (PAD) and Coronary Artery Disease (CAD).
AngioSoma, Inc. (SOAN), closed Friday's trading session at $0.09, up 28.39%, on 28,729 volume with 4 trades. The average volume for the last 60 days is 107,614 and the stock's 52-week low/high is $0.07/$0.52.
Ascent Solar Technologies, Inc. (ASTI)
Profitable Trader Authority, Promotion Stock Secrets, StreetInsider, PennyPro, SuperStockTips, InvestorSoup, Penny Stock Craze, Stock Preacher, Beacon Equity Research, Penny Stocks Finder, and InvestorsUnderground reported on Ascent Solar Technologies, Inc. (ASTI), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Ascent Solar Technologies, Inc. is a developer and manufacturer of state-of-the-art, flexible, thin-film photovoltaic (PV) modules integrated into its EnerPlex™ series of consumer products. The Company is a developer of award-winning thin-film photovoltaic modules with substrate materials that are more flexible, versatile, and stronger than traditional solar panels. EnerPlex is Ascent Solar Technologies’ brand of consumer products. EnerPlex is a division of Ascent Solar. Ascent Solar’s Research and Development (R&D) and its 30 MW nameplate production facility is in Thornton, Colorado.
The EnerPlex Division represents Ascent Solar's consumer-facing business and products. Ascent Solar’s technology is thin-film CIGS on flexible, plastic substrate. The Company’s manufacturing is roll-to-roll manufacturing, monolithic integration & intelligent process control. Its business divisions are: Solar Solutions - Aerospace, UAVs, Military, Specialty Applications, Consumer Market & Transportation; and
Power Storage Solutions - Mobility, Outdoor & Emergency Portable Power.
Ascent Solar Technologies’ flexible, lightweight CIGS modules enable seamless integration of solar power into an unlimited number of applications without the restrictions of normal glass panels. The Company’s modules can be directly integrated into consumer products and off-grid applications. Moreover, they can be directly integrated into aerospace and building integrated applications.
Ascent Solar Technologies has reached a breakthrough in power-to-weight ratio for its superlight solar module, delivering over 1700 watts of power per kilogram, operating at AM0, technically called the space environment. With this performance, its superlight module would weigh 66 percent less than a comparable PV system utilizing the highest-quality crystalline silicon and with much less design complexity.
In December, Ascent Solar Technologies announced that it was chosen by the Japan Aerospace Exploration Agency (JAXA) as part of their next round of evaluations for providing solar technology for an upcoming mission to Jupiter, and to address additional missions. This decision followed a previous round of investigation with promising results, during which Ascent Solar Technologies’ flexible, monolithically integrated copper-indium-gallium-selenide (CIGS) solar module was exposed to environmental extremes, and continued to operate well.
Ascent Solar Technologies, Inc. (ASTI), closed Friday's trading session at $0.0021, up 31.25%, on 164,907,358 volume with 813 trades. The average volume for the last 60 days is 31,413,846 and the stock's 52-week low/high is $0.0014/$2.60.
National Waste Management Holdings, Inc. (NWMH)
The QualityStocks Daily Newsletter would like to spotlight National Waste Management Holdings, Inc. (NWMH). Today, National Waste Management Holdings, Inc. closed trading at $0.12, up 9.09%, on 49,766 volume with 7 trades. The stock’s average daily volume over the past 60 days is 23,549, and its 52-week low/high is $0.06/$1.34.
National Waste Management Holdings, Inc. (NWMH) is a solid waste management company offering comprehensive solutions for full waste diversion along Florida's west coast and in upstate New York. With an established base of long-term partnerships with municipal, institutional, commercial and industrial customers, along with a successful acquisition strategy, National Waste has set its course to become a leading waste diversion company.
National Waste's 54-acre landfill facility located in Hernando, Florida, handles annual average disposals of roughly 240,000 cubic yards of construction debris annually. The site also offers an array of ancillary services such as roll-off dumpster services, mulching services and recycling. While the landfill facility is already permitted for future expansion, National Waste's growth strategy also calls for the opening of new satellite offices in counties and states that neighbor its existing operations.
In addition to increasing its geographic foothold, National Waste employs a strategic acquisition model to increase its overall market share. In 2015, the company acquired Gateway Rolloff Services LP and Waste Recovery Enterprises LLC, which are expected to generate a combined $3.8 million in annual revenue for National Waste moving forward. In the second quarter of 2016, National Waste added Sivart Services to its roster, creating an immediate source of additional revenue and expanding its foothold in the northeast area of New York.
Management has confirmed its interest in additional acquisition targets while demonstrating its ability to effectively integrate and organically grow the company's existing acquisition companies and maintain efficient operations. Disclaimer
National Waste Management Holdings, Inc. Company Blog
National Waste Management Holdings, Inc. News:
National Waste Management Holdings, Inc. Ends Year on High Note, Announces Final Acquisition of 2016
NetworkNewsWire Releases Exclusive Audio Interview with National Waste Management Holdings, Inc. (NWMH)
National Waste Management Holdings, Inc. (NWMH) Engages NetworkNewsWire for Corporate Communications Solutions
eXp World Holdings, Inc. (EXPI)
The QualityStocks Daily Newsletter would like to spotlight eXp World Holdings, Inc. (EXPI). Today, eXp World Holdings, Inc. closed trading at $3.514, off by 1.01%, on 4,805 volume with 13 trades. The stock’s average daily volume over the past 60 days is 11,422, and its 52-week low/high is $0.6101/$5.84.
eXp World Holdings, Inc. (EXPI) is the holding company for a number of businesses, most notably eXp Realty LLC, the Agent-Owned Cloud Brokerage™. eXp Realty is a full-service real estate brokerage offering 24/7 access to a suite of collaborative tools, training features and socialization channels designed to meet the unique needs of real estate brokers and agents. By creating a fully-immersive, cloud office environment for real estate professionals, eXp effectively reduces agents' overhead, increases their profits and provides greater service value to consumers.
Through eXp Realty's innovative platform, agents and brokers are afforded the opportunity to earn equity in exchange for production and contributions to company growth. Additionally, eXp features an aggressive revenue sharing program that pays agents a percentage of the gross commission income earned by fellow professionals they recruit into the company. The result is a shared ownership community featuring a synergistic and collaborative group of forward-thinking, entrepreneurial professionals. With the emergence of the internet as the most powerful property marketing and advertising medium, eXp's internet and cloud technologies have helped thousands of consumers find, buy or sell homes without the need for a brick and mortar real estate office.
Since its launch in October 2009, eXp Realty has experienced rapid growth, with brokerage service now offered in 35 U.S. states and Alberta, Canada. In February 2016, the company officially welcomed its 1,000th real estate professional into its family of agent-owners, up from just 467 agents at the end of 2014. Following this achievement, the Agent-Owned Cloud Brokerage claimed a spot among the top 50 real estate brokerages in the United States based on agent count, according to data from RISMEDIA's 2015 PowerBroker 500 Report.
Similarly, eXp Realty generated record financial results during 2015. Following the launch of two new initiatives – including an online lead generation program and a stock compensation plan – the company achieved a 71 percent year-over-year increase in net revenues, recording $22.87 million for the year. As it continues to expand its footprint across North America, eXp Realty will look to leverage its unique agent-owned business model to continue attracting driven, entrepreneurial agents and real estate industry leaders while promoting sustainable financial growth. Disclaimer
eXp World Holdings, Inc. Company Blog
eXp World Holdings, Inc. News:
eXp Realty Nearly Triples Agent Count in 2016
eXp World Holdings, Inc. Announces Appointment of Independent Director
eXp World Holdings, Inc. Retains MZ Group as its Investor Relations Advisor
Monaker Group, Inc. (MKGI)
The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.20, off by 10.20%, on 22,980 volume with 16 trades. The stock’s average daily volume over the past 60 days is 10,081, and its 52-week low/high is $1.10/$5.00.
Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.
NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.
Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.
Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.
In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.
With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.
Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer
Monaker Group, Inc. Company Blog
Monaker Group, Inc. News:
Monaker Group Appoints Simon Orange to Board of Directors Appointment Advances Monaker's Plans for NASDAQ Listing
Monaker Group Shareholder Update -- 2016 Milestones and Transactional Business
Monaker Group (MKGI): Tip of the Travel Industry Iceberg -- SECFilings.com
GainClients, Inc. (GCLT)
The QualityStocks Daily Newsletter would like to spotlight GainClients, Inc. (GCLT). Today, GainClients, Inc. closed trading at $0.0367, off by 8.02%, on 31,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 145,069, and its 52-week low/high is $0.01/$0.20.
GainClients, Inc. (GCLT) is a software service company focused primarily on the development of marketing services for real estate professionals and valuable home search and area information tools for consumers. The company's innovations expound the popularity of online networks by helping real estate professionals better serve their clients through the sharing of accurate real estate data.
The company's main product is the GCard progressive networking system, which is designed to build and promote relationships among real estate professionals and their clients. Using the GCard, agents and brokers have the means to offer real estate, lending and title services information through an integrated, web-based network, capitalizing on the ongoing shift in consumer preference toward mobile solutions.
Similar to the features of other popular online networks, professional users can invite clients and their industry partners to join their GCard networks and be featured as trusted team members. From here, the teams can quickly provide real estate, lending and title services and information to consumers via smartphone and web. With better communication throughout the process of buying or selling homes, purchases can move more quickly and more comfortably to completion.
Strategic partnerships are an important component of GainClients' growth strategy. The company recently established a worldwide licensing arrangement with CLOVIS LLC, a partnership that will enable the distribution of both companies' proprietary technologies to the real estate industry. CLOVIS will use GainClients' GCard to develop a unique lead generation program for the broader real estate marketing and advertising industry.
GainClients also offers GCHomeSearch, its stand-alone website that provides non-real estate customers, such as lenders and title professionals, with accurate listing data, historical property data, neighborhood information and demographics. When used with the GCard, the user is also privy to loan payment calculators, loan rates, closing cost estimators and other tools needed to make intelligent buying and selling choices. Disclaimer
GainClients, Inc. Company Blog
GainClients, Inc. News:
GainClients, Inc. Retains Largest Real Estate Customer on its GCard Service
GainClients, Inc. Announces Corporate Update
GainClients, Inc. Enters Into A Licensing Agreement with Real Estate Technology Upstart CLOVIS, LLC To Expand Its Technology Platform
Singlepoint, Inc. (SING)
The QualityStocks Daily Newsletter would like to spotlight Singlepoint, Inc. (SING). Today, Singlepoint, Inc. closed trading at $0.0191, off by 3.54%, on 5,266,595 volume with 262 trades. The stock’s average daily volume over the past 60 days is 2,922,932, and its 52-week low/high is $0.0046/$0.0245.
Singlepoint, Inc. (SING) provides mobile technology and marketing solutions that enable companies, nonprofits and religious organizations to conduct business transactions, accept donations, and engage in targeted communication via mobile devices. Through diversification of its own model, the company is also leveraging its core technology to expand into the mobile auctions and daily fantasy sports markets.
SING currently has two fundraising solutions. Text2Bid is an interactive way to increase auction revenues. The technology makes it easy for people to bid in auctions from any text or web-enabled phone. Donate by Text allows nonprofits to securely collect one-time or recurring donations via text. This capability creates a personal experience for the donors, and enables ongoing communication between the donor and nonprofit or event sponsor.
SING's payment solutions include point-of-sale (POS) terminals, loyalty programs, payment processing, phone services and financing. Pay by Text™ enables a business to accept payment transactions and, in essence, turns the user's mobile phone into a point-of-sale device. Operating on the same platform as mobile marketing, Pay by Text is designed to increase revenues, raise the average per-transaction amount, and create a fast, easy and hassle-free method of payment.
As part of its diversification and expansion strategy, SING recently acquired an interest in DraftFury (www.draftfury.com), a company that offers skill-based NBA, NFL and MLB daily fantasy sports (DFS) contests. DraftFury is known for its innovative offerings and originality, and is the first cash-flow-positive DFS enterprise. This transaction places SING in a multi-billion dollar industry expected to generate entry fees of $14.4 billion in 2020. Under the guidance of a leadership team well-versed in technology, engineering, marketing and raising capital, SING anticipates a strong foothold in its chosen markets. Disclaimer
Singlepoint, Inc. Company Blog
Singlepoint, Inc. News:
Senate Banking Committee Could Pave the Way to a Bankable Marijuana Industry
SinglePoint Subsidiary: Opportunities High Amid Congressional Call for Cannabis Banking Reform
MoneyTV with Donald Baillargeon, 12/16
Today's Top 3
Trader Power News
Profitable Trader Authority
The QualityStocks Public Company Sponsor News